Learn more

EPIDAUROS BIOTECHNOLOGIE AG

Overview
  • Total Patents
    83
About

EPIDAUROS BIOTECHNOLOGIE AG has a total of 83 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are EXONHIT THERAPEUTICS SA, OXO CHEMIE AG and OXFORD BIODYNAMICS LTD.

Patent filings per year

Chart showing EPIDAUROS BIOTECHNOLOGIE AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Brinkmann Ulrich 25
#2 Kerb Reinhold 25
#3 Wojnowski Leszek 18
#4 Heinrich Guenther 15
#5 Hoffmeyer Sven 10
#6 Hustert Elisabeth 9
#7 Roots Ivar 8
#8 Eichelbaum Michel 7
#9 Eiselt Regina 6
#10 Zanger Ulrich 5

Latest patents

Publication Filing date Title
AU2003264094A1 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications
AU2003237657A1 Means and methods for improved treatment using "setrones"
AU2003240253A1 Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications
AU2003244498A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
WO03014387A2 Polymorphisms in the human gene for cyp1a2 and their use in diagnostic and therapeutic applications
AU2002328950A1 Methods for treatment of cancer using irinotecan based on ugt1a1
ZA200200773B Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications.
CA2432339A1 Identification of the genetic determinants of the polymorphic cyp3a5 expression
WO0224747A2 Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applications
AU8584201A Improved novel assay for screening compounds capable of inducing drug metabolizing enzymes
EP1272663A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
AU5791301A Polymorphisms in the human CYP2D6 gene promoter region and their use in diagnostic and therapeutic applications
AU4052101A (CA)<sub>n</sub> polymorphisms in an intron of the endothelial nitric oxide synthase gene and their use in diagnostic and therapeutic applications
EP1337661A1 Methods for diagnosing individuals with an increased risk to develop a deficiency based on mdr1 gene polymorphism
AU3155001A Use of mdr-1 inducers for treating or preventing diseases
HU0201997A2 Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
US6645745B1 Identification of a new member of the cytochrome P450 3A (CYP3A) gene family: CYP3AX
EP1130112A1 Method for detecting the presence of at least one single allele of a deletion mutant
DE19963490A1 Genotyping multidrug resistance gene-1, useful for assessing doses of pharmaceuticals, by mass spectrometric analysis of primer extension products
EP1088900A1 Polymorphisms in the human CYP3A4, CYP3A7 and hPXR genes and their use in diagnostic and therapeutic applications